Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -220,872 | -160,419 | -107,206 | -55,894 | -123,603 |
| Depreciation Amortization | 8,307 | 7,494 | 6,660 | 1,022 | 4,614 |
| Accounts payable and accrued liabilities | 2,664 | 2,381 | 4,448 | 616 | 2,394 |
| Other Working Capital | 19,809 | 9,858 | 6,539 | 2,841 | 9,618 |
| Other Operating Activity | 36,411 | 28,096 | 21,402 | 20,854 | 53,715 |
| Operating Cash Flow | $-153,681 | $-112,590 | $-68,157 | $-30,561 | $-53,262 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -45,054 | -65,054 | -89,554 | -89,554 | N/A |
| PPE Investments | -4,424 | -3,054 | -1,966 | -916 | -1,452 |
| Purchase Sale Intangibles | -633 | -628 | -465 | -195 | -671 |
| Other Investing Activity | -922 | -916 | -665 | -195 | -671 |
| Investing Cash Flow | $-50,400 | $-69,024 | $-92,185 | $-90,665 | $-2,123 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 4,375 |
| Debt Repayment | -1,454 | -1,092 | -729 | -365 | -1,466 |
| Common Stock Issued | 22,994 | 20,684 | 18,163 | 15,859 | 255,929 |
| Other Financing Activity | -4,336 | -2,615 | -2,615 | -2,302 | -827 |
| Financing Cash Flow | $17,204 | $16,977 | $14,819 | $13,192 | $258,011 |
| Beginning Cash Position | 306,256 | 306,256 | 306,256 | 306,256 | 103,630 |
| End Cash Position | 119,379 | 141,619 | 160,733 | 198,222 | 306,256 |
| Net Cash Flow | $-186,877 | $-164,637 | $-145,523 | $-108,034 | $202,626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -153,681 | -112,590 | -68,157 | -30,561 | -53,262 |
| Capital Expenditure | -4,424 | -3,054 | -1,966 | -916 | -1,452 |
| Free Cash Flow | -158,105 | -115,644 | -70,123 | -31,477 | -54,714 |